Logo image of ACB

AURORA CANNABIS INC (ACB) Stock Price, Forecast & Analysis

USA - NASDAQ:ACB - CA05156X8504 - Common Stock

4.95 USD
+0.14 (+2.91%)
Last: 10/31/2025, 8:25:10 PM
5.03 USD
+0.08 (+1.62%)
After Hours: 10/31/2025, 8:25:10 PM

ACB Key Statistics, Chart & Performance

Key Statistics
Market Cap278.44M
Revenue(TTM)357.88M
Net Income(TTM)-19461000
Shares56.25M
Float56.22M
52 Week High6.91
52 Week Low3.42
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.25
PEN/A
Fwd PE14.78
Earnings (Next)11-05 2025-11-05/bmo
IPO2007-09-26
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


ACB short term performance overview.The bars show the price performance of ACB in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 -10

ACB long term performance overview.The bars show the price performance of ACB in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -20 -40 -60

The current stock price of ACB is 4.95 USD. In the past month the price decreased by -12.39%. In the past year, price decreased by -10.65%.

AURORA CANNABIS INC / ACB Daily stock chart

ACB Latest News, Press Relases and Analysis

ACB Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 39.24 816.66B
JNJ JOHNSON & JOHNSON 18.2 454.86B
AZN ASTRAZENECA PLC-SPONS ADR 18.56 255.48B
NVS NOVARTIS AG-SPONSORED ADR 13.83 239.64B
NVO NOVO-NORDISK A/S-SPONS ADR 12.81 219.77B
MRK MERCK & CO. INC. 9.87 214.76B
PFE PFIZER INC 7.27 140.15B
SNY SANOFI-ADR 11.52 123.27B
GSK GSK PLC-SPON ADR 7.73 94.25B
BMY BRISTOL-MYERS SQUIBB CO 7.02 93.77B
ZTS ZOETIS INC 23.17 63.86B
TAK TAKEDA PHARMACEUTIC-SP ADR 48 42.45B

About ACB

Company Profile

ACB logo image Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

Company Info

AURORA CANNABIS INC

2207 90B Street Sw

Leduc ALBERTA T5J 1Y6 CA

CEO: Terry Booth

Employees: 1101

ACB Company Website

ACB Investor Relations

Phone: 16043625207

AURORA CANNABIS INC / ACB FAQ

Can you describe the business of AURORA CANNABIS INC?

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


Can you provide the latest stock price for AURORA CANNABIS INC?

The current stock price of ACB is 4.95 USD. The price increased by 2.91% in the last trading session.


Does ACB stock pay dividends?

ACB does not pay a dividend.


How is the ChartMill rating for AURORA CANNABIS INC?

ACB has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the expected growth for ACB stock?

The Revenue of AURORA CANNABIS INC (ACB) is expected to grow by 8.72% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is the market capitalization of ACB stock?

AURORA CANNABIS INC (ACB) has a market capitalization of 278.44M USD. This makes ACB a Micro Cap stock.


What is the ownership structure of AURORA CANNABIS INC (ACB)?

You can find the ownership structure of AURORA CANNABIS INC (ACB) on the Ownership tab.


ACB Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to ACB. When comparing the yearly performance of all stocks, ACB is a bad performer in the overall market: 65.48% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ACB Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ACB. ACB may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ACB Financial Highlights

Over the last trailing twelve months ACB reported a non-GAAP Earnings per Share(EPS) of -0.25. The EPS increased by 44.79% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -2.32%
ROE -3.53%
Debt/Equity 0.07
Chartmill High Growth Momentum
EPS Q2Q%-307.69%
Sales Q2Q%17.48%
EPS 1Y (TTM)44.79%
Revenue 1Y (TTM)28.42%

ACB Forecast & Estimates

9 analysts have analysed ACB and the average price target is 5.81 USD. This implies a price increase of 17.38% is expected in the next year compared to the current price of 4.95.

For the next year, analysts expect an EPS growth of -288.53% and a revenue growth 8.72% for ACB


Analysts
Analysts73.33
Price Target5.81 (17.37%)
EPS Next Y-288.53%
Revenue Next Year8.72%

ACB Ownership

Ownership
Inst Owners15.09%
Ins Owners0.03%
Short Float %11.69%
Short Ratio3.85